Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SYRE

Spyre Therapeutics Inc

May 22 • 04:00PM ET

74.05

-0.27 -0.36 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: LKFT ROIV APLS VERA KYMR

| Held by: VTI IWM XBI VXF IBB IWO VTWO SCHA IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.36	Insider Own	11.54%	Shs Outstand	78.84M	Perf Week	-1.16%
Market Cap	6.43B	Forward P/E	-	EPS next Y	-3.15	Insider Trans	-2.71%	Shs Float	77.28M	Perf Month	6.95%
Enterprise Value	5.84B	PEG	-	EPS next Q	-0.73	Inst Own	87.14%	Short Float	15.81%	Perf Quarter	67.61%
Income	-168.74M	P/S	-	EPS this Y	-47.69%	Inst Trans	1.78%	Short Ratio	11.14	Perf Half Y	204.73%
Sales	0.00M	P/B	11.34	EPS next Y	-7.78%	ROA	-25.30%	Short Interest	12.22M	Perf YTD	126.04%
Book/sh	6.53	P/C	8.67	EPS next 5Y	-21.87%	ROE	-29.26%	52W High	78.80 -6.03%	Perf Year	391.37%
Cash/sh	8.54	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-25.15%	52W Low	13.93 431.58%	Perf 3Y	1874.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.85% 6.12%	Perf 5Y	-59.65%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	22.31%	Oper. Margin	-	ATR (14)	4.40	Perf 10Y	-60.29%
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	57.91	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	-46.71%	SMA20	1.93%	Beta	3.10	Target Price	95.20
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	20.37%	Rel Volume	0.52	Prev Close	74.32
Employees	102	LT Debt/Eq	0.00	Earnings	May 05 BMO	SMA200	108.90%	Avg Volume	1.10M	Price	74.05
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.18% -	Trades		Volume	574,913	Change	-0.36%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)